A case of hepatic-splenic abscess in a non-endemic area of brucellosis: insights from complex infection with brucellosis
Abstract
We present the case of a 47-year-old male patient who exhibited recurrent fever and was diagnosed with liver and splenic abscesses. Magnetic Resonance Imaging of the upper abdomen showed several hypodense lesions in the liver and spleen. A puncture of the liver abscess was performed and the sample was subjected to Next-Generation Sequencing (NGS). The results of both the liver sample and blood NGS indicated the presence of Brucella. Further examination of the liver and spleen pus suggested necrotizing purulent inflammation. Consequently, the final diagnosis confirmed the condition as brucellosis, liver abscess, and splenic abscess. Doxycycline, rifapentine, and levofloxacin were administered to treat the infection. However, the results were suboptimal. Subsequently, the patient underwent a splenectomy and open drainage of an abscess of the liver. Following the surgical intervention, the patient's symptoms improved gradually and he continued his regimen of doxycycline, rifapentine, and trimethoprim-sulfamethoxazole therapy. This triple-drug combination was maintained for a duration of up to 32 months to effectively control the infection and was ultimately discontinued after a thorough evaluation of the stable lesion. For brucellosis patients with abdominal abscesses, effective treatment requires surgical debridement and extended anti-infective therapy.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.